We use cookies to improve your browsing experience on our website.
Please visit our Privacy Notice for more information about cookies and how we use them. We recommend that you accept the use of cookies for better navigation.


August 15, 2019
KCI Signs Collaborative Research Agreement with UT Health San Antonio

KCI, an Acelity Company, has signed a collaborative research agreement with UT Health San Antonio. The five-year agreement will allow the organizations to compile a body of research measuring the clinical effectiveness and economic benefit of KCI’s advanced wound care therapies and further UT Health San Antonio’s understanding of healing outcomes and associated costs with different therapies and care protocols, all while improving San Antonio’s footprint in innovation and research in wound care.

The San Antonio-based organizations will work together to design research studies analyzing KCI’s advanced wound care solutions. The agreement will allow for medical students, fellows, residents, nurses and other faculty to design and conduct quality outcomes research. The first study will be conducted in conjunction with UT Health San Antonio’s Department of Orthopaedics, focused on KCI’s surgical management solutions. 

“At KCI, we have a steadfast commitment to evidence-based outcomes, and we are always looking to work with partners who have the same goals that we do – restoring people’s lives,” said Ronald Silverman, M.D., FACS, Chief Medical Officer, KCI. “Our relationship with UT Health San Antonio will help us continue to move healing forward and will further support our efforts to provide customers and patients with the best possible solutions backed by proven clinical data.”

“Agreements like this are integral to continued medical innovation and cutting-edge research. Given their position in the advanced wound care industry, we’re keen to explore what we can discover about advanced wound care together with KCI, and further our contribution to the academic research community in this important area,” said Boris A. Zelle, M.D., Associate Professor and Vice Chair of Research, Department of Orthopaedics at UT Health San Antonio.

About KCI, an Acelity Company
KCI, an Acelity Company, is a well trusted brand in advanced wound care. We are a leader in negative pressure wound therapy, providing solutions for both wound healing and surgical management. Our product offerings are available in more than 90 countries and deliver value through solutions that speed healing. KCI is a leader in quality, safety and customer experience and is committed to advancing the science of healing. Headquartered in San Antonio, Texas, KCI employs approximately 4,500 people worldwide.

About UT Health San Antonio
The University of Texas Health Science Center at San Antonio, now called UT Health San Antonio®, is one of the country’s leading health sciences universities. With missions of teaching, research, healing and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced 36,500 alumni who are leading change, advancing their fields and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit www.uthscsa.edu.


Stay connected with UT Health San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.

For more information, contact: 


Maggie Fairchild

Corporate Communications

Phone: +1-210-330-2667

Email: maggie.fairchild@acelity.com


Jathan Tucker,

Investor Relations

Phone: +1-210-255-6817

Email: jathan.tucker@acelity.com